UNSPSC 51351702: Fenestrel

This classification denotes a non-steroidal estrogen with the molecular formula C16H20O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LEC4215V9R, chemically known as 3-cyclohexene-1-carboxylic acid, 5-ethyl-6-methyl-4-phenyl- but generally known as fenestrel, which bears US NIH Compound Identifier 24371. European Medicines Agency schedules Fenestrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07557MIG. The term FENESTREL is an International Non-Proprietary Name.

UNSPSC 51351702 Fenestrel is a Commodity code encompassing window and door components manufactured from synthetic materials. State and local governments procure fenestrel products primarily through cooperative purchasing agreements and multi-source contracts that aggregate demand across participating agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represents the primary issuing model for this category, coordinating procurement on behalf of state departments, counties, municipalities, and other public facilities across multiple states including Oregon. Scope of work under the code includes supplying fenestrel products meeting FDA compliance and cGMP standards, with vendors required to maintain relationships with authorized wholesalers, submit detailed product specifications and SKUs, and demonstrate pricing flexibility through multiple rate structures. Issuing bodies are predominantly state purchasing offices administering cooperative agreements rather than individual municipalities or special districts, reflecting the consolidated procurement model that dominates this commodity space.

The code shows activity concentrated in the Upper Midwest and Pacific Northwest, with recent solicitations spanning Minnesota and Oregon through MMCAP's multi-state vehicle. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, with a response deadline of March 26, 2026, to establish multiple contracts for generic multi-source products effective July 1, 2026. Evaluation criteria weight price competitiveness at 75 percent, compliance with administrative data requirements at 5 percent, EDI capability at 5 percent, and fixed pricing at 10 percent; vendors must carry commercial general liability insurance of $5,000,000 per occurrence and network security and privacy liability of $2,000,000, and agree to a 3 percent administrative fee on all purchases. No specific set-aside designations are identified in the available documentation, and award values are not disclosed; however, the two-year initial contract term with optional extensions suggests sustained procurement activity across the participating cooperative membership.